Publikationen & Vorträge

Publikationen

-           Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays, Spaeth A, Masetto T, Brehm J, Wey L, Kochem C, Brehm M, Peter C, Grimmler M, Diagnostics 11(8) 1332, 2021

-           Ethyl glucuronide and ethanol concentrations in femoral blood, urine and vitreous humor from 117 autopsy cases, Neumann J, Keller T, Monticelli F, Beck O, Böttcher M, Forensic Sci Int 318, 1-7, 2021

-           Weder Zauberpilz noch Krötenschleim – Zur Differenzierung von Bufotenin und Psilocin mit dem Toxtyper, Stemmerich K, Schulz K, Peschel A, Böttcher M, Arndt T, Toxichem Krimtech, 88(1), 51-62, 2021

-           Der CEDIA Probenkontroll-Assay – Einsatzmöglichkeiten und Grenzen eines Probenintegritätstests, Franz S, Skopp G, Böttcher M, Musshoff F, Zeitschrift für Verkehrssicherheit 66, 313-316, 2020

-           Sensitive determination of ethyl glucuronide in serum and whole blood: detection time after alcohol exposure compared with urine, Neumann J, Beck O, Helander A, Dahmen N, Böttcher M, J Lab Med 44(4): 211-219, 2020

-           Challenges of LC-MS/MS Ethyl Glucuronide analysis in abstinence monitoring of liver transplant patients, Heinemann ML, Elsing L, Kaiser T, Boettcher M, Herber A, Seehofer D, Berg T, Ceglarek U, Clin Chem Lab Med. 58(8), 1265-1270, 2020

-           Performance of PEth compared with other alcohol biomarkers in subjects presenting for occupational and pre-employment medical examination, Neumann J., Beck O, Helander A, Böttcher M, Alcohol and Alcoholism 55(4), 401-408, 2020

-           Prolonged ketamine and norketamine excretion profiles in urine after chronic use, de Jong LAA, Qurishi R, Stams M, Böttcher M, de Jong CAJ, J Clin Psychopharmacol, 40 (3), 300-304, 2020.

-           Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy, Vierke C, Marxen B, Boettcher M, Hiemke C, Havemann-Reinecke U, Eur Arch Psychiatry Clin Neurosci., published online 01/2020

-           Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse) using oral fluid as specimen, Böttcher M, Kühne D, Beck O, Clinical Mass Spectrometry 14, 99-105, 2019 

-           Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology guideline: development and validation of Dried Blood Spot-based methods for Therapeutic Drug Monitoring, Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O, Keevil BG, Koch BCP, Linden R, Pistos C, Stolk LM, Touw DJ, Stove CP, Alfenaar J-WC, Ther Drug Monit, 41: 409-430, 2019;

-           Elimination characteristics of the alcohol biomarker phosphatidylethanol (PEth) in blood during alcohol detoxification, Helander A, Böttcher M, Dahmen N, Beck O, Alcohol and Alcoholism 54(3), 251-257, 2019 

-           Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing, Böttcher M, Lierheimer S, Peschel A, Beck O, Drug and Alcohol Dependence 198, 136-139, 2019

-           Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine, Picht F, Beck O, Böttcher M, Drug Test Anal. 11(3), 536-540, 2019

-           Creatinine excretion in consecutive urine samples after controlled ingestion of water, Franz S, Skopp G, Böttcher M, Musshoff F, Drug Test Anal. 11(3), 435-440, 2019

-           A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry, Reinstadler V, Lierheimer S, Böttcher M, Oberacher H, Analytical and Bioanalytical Chemistry 411: 867-876, 2019

-          Aktuelle Nachweismethoden von Substanzkonsum, Böttcher M, Waizmann M, Ärzteblatt Sachsen, 343-345, 08/2018

-          Oral fluid – a suitable specimen for compliance testing in psychopharmacotherapy and substitution therapy, Böttcher M, Beck O, The IATDMCT Compass Vol 17,1, 2018

-          Potential of oral fluid as a clinical specimen for compliance monitoring of  psychopharmacotherapy, Neumann J, Beck O, Dahmen N, Böttcher M, Ther Drug Monit, 40: 245-251, 2018

-          Salivary neuropeptides, stress, and periodontitis, Haririan H, Andrukhov O, Böttcher M, Pablik E, Wimmer G, Moritz A, Rausch-Fan X, J Periodontol 89, 9-18, 2018.  

-          Sevoflurane metabolite cross-react in the ethyl glucuronide DRI immunoassay, Böttcher M, Kühne D, Beck O, Drug Test Anal. 10(2), 379-380, 2018

-          Induction of autophagy reduces ischemia/reperfusion injury in steatotic rat livers, Kan C, Liu A, Fang H, Dirsch O, Dahmen U, Boettcher M, J Surg Res., 216, 207-218, 2017

-          Integration of clinical examination, self-report, and hair ethyl glucuronide analysis for evaluation of patients with alcoholic liver disease prior to liver transplantation, Beckmann M, Paslaki G, Böttcher M, Helander A, Erim Y, Progress in Transplantation, 26 (1), 40-46, 2016

-          Feasibility and acceptability of an alcohol addiction therapy integrated in a transplant center for patients awaiting liver transplantation, Erim Y, Böttcher M, Schieber K, Lindner M, Klein C, Paul A, Beckebaum S, Mayr A, Helander A, Alcohol Alcohol. 51 (1), 40-46, 2016

-          Stabilitätsuntersuchungen zu Ethylglucuronid bei bakteriell kontaminierten Urinen , Bartling C, Böttcher M, Toxichem Krimtech; 82 (Special Issue): 199-201, 2015.

-          Evaluation of a commercial LC-MS/MS assay for the quantification of ethyl glucuronide in urine for alcohol intake monitoring, Becker S, Brauer R, Böttcher M, Thiery J, Ceglarek U, J Lab Med 39(3): 159-163, 2015

-          Drogen- und Medikamententestung im Speichel, Böttcher M, Trillium Diagnostik 12(2), 82-83, 2014

-          Salivary and serum chromogranin A and alpha-amylase in periodontal health and disease, Haririan H, Bertl K, Laky M, Rausch W-D, Böttcher M, Matejka M, Andrukhov O, Rausch-Fan X, J Periodontology, 2012

-          An enzymatic method to determine y-hydroxybutyric acid in serum and urine, Hasan L, Jermann T M, Weber J, Abrahamsson L, Sciotti M-A, Böttcher M, Jöchle W, Gygax D, Scholer A, Ther Drug Monit 33, No. 6, 757-765, 2011

-          Study on the sampling of methadone from exhaled breath, Beck O, Sandqvist S, Böttcher M, Eriksen P, Franck J, Palmskog G, JAT 35, No. 5, 257-263, 2011

-          Quantification of 11-nor-9-carboxy-delta9-tetrahydrocannabinol (CTHC) Equivalents in Urine using instrumentally read Gold-labeled Lateral Flow Immunoassays (IRGLFIA) in Order to Predict THC in Serum >= 1 ng/mL, Haisser J, Tiemann B, Protzek C, Boettcher M, Aderjan R, Toxichem Krimtech 78 (Special Issue), p. 332-336, 2011



Veröffentlicht am: 2021-07-29 08:22:37